Evolv Technologies Holdings, Inc. (EVLV) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary indicates strong financial performance with a 40% increase in full-year revenue and a significant improvement in adjusted EBITDA. The Q&A section revealed positive sentiment towards future revenue growth, driven by strategic changes and anticipated ARR acceleration. Despite some execution risks, the company's strategic initiatives, including the Plexus partnership and AHA certification, are expected to enhance growth. The raised revenue guidance and positive cash flow expectations for 2026 further support a positive outlook, suggesting a likely stock price increase of 2% to 8%.
Key Financial Performance
Annual Recurring Revenue (ARR) $120.5 million, reflecting growth of 21% year-over-year. The growth was fueled by new customer growth and expanding deployments across the customer base.
Q4 Revenue $38.5 million, up 32% year-over-year. Growth was driven by strong new customer acquisitions, continued expansion within existing customers, and a step-up of approximately $15 million in the second half of product revenue due to the decision to directly fulfill purchase subscriptions.
Full Year Revenue $145.9 million, representing growth of 40% year-over-year. Growth was primarily driven by strong demand and a $15 million year-over-year growth in revenue from the shift to directly fulfilling hardware portion of purchase subscription orders.
Adjusted EBITDA (Q4) $1.8 million, with an adjusted EBITDA margin of 4.7%. This is an improvement from $400,000 in the fourth quarter of the previous year, driven by revenue growth and operational leverage.
Adjusted EBITDA (Full Year) $11.1 million, with an adjusted EBITDA margin of 7.6%. This is a $32 million improvement from the prior year's loss of $21 million, driven by higher revenue and improved margins.
Remaining Performance Obligation (RPO) $293.4 million at the end of Q4, a 13% year-over-year increase. Growth was driven by upgrades to the Gen2 Express platform and solid end market demand.
Cash, Cash Equivalents, and Marketable Securities $69 million, an increase of $12.8 million sequentially in Q4. This increase reflects strong cash collection efforts and disciplined working capital management.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Weapons Detection as a Service: Evolv provides a comprehensive solution combining hardware, software, AI models, and on-site services. By the end of 2025, 8,000 systems were deployed, screening over 4 million people daily. The company also launched the eXpedite AI-based bag screening solution, which has been adopted by 65 customers in its first year.
Education Sector: Added 65 new education customers in 2025, screening approximately 300 million students and visitors. Expanded presence in schools and universities across the U.S.
Healthcare Sector: Partnered with the American Hospital Association, gaining access to nearly 5,000 member hospitals. Added notable customers like William P. Clements Jr. University Hospital and University of Oklahoma Medical Center.
Sports and Entertainment: Added 65 new customers in 2025, including 7 professional football teams. Upgraded systems for major venues like TD Garden and Crypto.com Arena.
Workplace Security: Secured multiple Fortune 500 companies, including a top 10 global bank and a Fortune 100 healthcare innovator.
Financial Performance: Achieved $145.9 million in revenue for 2025, a 40% year-over-year growth. Annual recurring revenue (ARR) reached $120.5 million, up 21% year-over-year. Adjusted EBITDA improved to $11.1 million from a $21 million loss in 2024.
Operational Efficiency: Shifted to direct fulfillment of purchase subscriptions, improving long-term revenue and cash flow despite short-term gross margin impacts.
Strategic Partnerships: Formed a partnership with the American Hospital Association to expand in the healthcare sector.
Product Innovation: Focused on AI advancements and expanding the product portfolio, including the successful launch of eXpedite.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Conditions: The global security environment is becoming increasingly complex, with escalating threat levels across public venues, schools, workplaces, and critical infrastructure. This increases the demand for scalable and reliable security solutions, but also presents challenges in meeting these heightened expectations.
Competitive Pressures: The discussion of generative AI and its potential to disrupt pure SaaS models highlights competitive pressures. While Evolv is not a pure SaaS company, the evolving technology landscape could pose challenges to maintaining its competitive edge.
Regulatory Hurdles: No explicit mention of regulatory hurdles was made in the transcript.
Supply Chain Disruptions: The company faces near-term gross margin headwinds due to the shift to direct fulfillment of purchase subscription orders, which impacts initial revenue and gross margin percentages.
Economic Uncertainties: The transcript does not explicitly mention economic uncertainties impacting the company.
Strategic Execution Risks: The transition to a direct fulfillment model, while beneficial in the long term, creates short-term challenges in gross margin and operational adjustments. Additionally, the company’s reliance on continued innovation in AI, hardware, and software to maintain its market position presents execution risks.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Expectations: The company is modeling full year 2026 revenue of $172 million to $178 million, representing year-over-year growth of approximately 18% to 22%. Revenue growth is expected to be driven by a 50-50 mix between purchase subscription and pure subscription.
Annual Recurring Revenue (ARR): The company expects to exit 2026 with ARR of approximately $145 million to $150 million, representing growth of about 20% to 25% year-over-year. The company ended 2025 with $120 million in ARR, providing a solid baseline for 2026.
Adjusted EBITDA Margins: The company is modeling full year adjusted EBITDA margins to expand from 7.6% in 2025 to the high single digits for 2026, despite a $1 million headwind on memory chip costs.
Deployment Expectations: The company expects to end 2026 with comfortably over 10,000 units deployed, up from 8,000 units at the end of 2025.
Market Trends and Strategic Plans: The company anticipates weapon screening to become standard infrastructure in certain types of buildings, similar to sprinkler systems and intrusion alarms. It plans to achieve this through relentless innovation in weapon detection accuracy, form factor, and cost.
Long-Term Financial Framework: The company plans to share more details about its long-term operating model, which is expected to show greater long-term leverage and adjusted EBITDA margins exceeding the previously stated range of 10% to 15%, at its 2026 Investor Day on June 9.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Why did the company raise its revenue guidance significantly despite modest sequential ARR growth in Q4?
A:The company anticipates ARR to accelerate throughout the year due to changes made last year, such as bringing purchase subscriptions back in-house and adjusting pricing by lowering upfront hardware costs and increasing software and service prices. Subscription ARR growth is also higher compared to purchase subscriptions.
Q:What caused the sequential improvement in subscription gross margins and the decline in service gross margins?
A:The changes in pricing models and the conscious decision to push more gross profit dollars into RPO for future periods contributed to these trends. Additionally, there was a $1 million accrual for targeted service costs incurred during the period.
Q:When is production from the Plexus relationship expected to begin, and how will it impact financials?
A:Production from Plexus is expected to reach full ramp in the second half of 2026. This transition is anticipated to provide a slight tailwind to gross margins over time and improve working capital.
Q:How does the company link its adjusted EBITDA forecast for 2026 to cash flow expectations?
A:The company expects to be cash flow positive in the second half of 2026, despite incremental cash costs in Q1 for prior year incentives. While cash flow improvement is anticipated, specifics on whether it will exceed 2025 levels are yet to be determined.
Q:What is the mix between new logos and existing customers, and how is it expected to trend?
A:The mix has historically been close to 50-50 between new customers and existing customers expanding. This trend is expected to continue.
Q:What are the hiring plans for fiscal 2026?
A:The company plans to invest in R&D, sales, and marketing while maintaining responsible expense growth. Headcount is expected to remain approximately flat, with a focus on in-sourcing services previously handled by contractors.
Q:What percentage of bookings come from current customers versus new customers, and what is expected in 2026?
A:Approximately 50% of bookings come from current customers, and 50% from new customers. This trend is expected to continue in 2026.
Q:Will the AHA certification accelerate hospital deals this year?
A:Yes, the AHA certification is expected to accelerate hospital deals. Additionally, regulatory mandates in states like California and Georgia for advanced weapon screening are seen as tailwinds for growth.
Q:Review of Unclear Management Responses
A:Management avoided providing a clear answer on whether cash flow in 2026 will definitively exceed 2025 levels, citing incremental costs and the need for further analysis later in the year.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI model
ARR RPO
Boston
Fortune
Investor Day
Investor Relations
RPO end
SaaS
Service
St
access
backlog
bag
change
combination
contract
demand increase
discipline capital
dollar
eXpedite
end market
entry
facility
fulfillment
hardware software
health care
incident
market demand
model decision
product portfolio
purchase subscription
security cash
service
software AI
solution stack
stack hardware
step product
student staff
threat
upgrade
weapon screening
workplace
EVLV Transcript
Evolv Technologies Holdings, Inc. (EVLV) Presents at TD Cowen's 54th Annual Technology, Media & Telecom Conference Transcript
Neutral5-29
Evolv Technologies Holdings, Inc. (EVLV) Q1 2026 Earnings Call Prepared Remarks Transcript
Positive5-18
The earnings call highlights strong revenue growth of 45% YoY and improved customer acquisition efficiency. The company is expanding its eXpedite platform and has an upcoming Investor Day to discuss strategy and innovation. Despite potential risks from the dynamic global security environment and generative AI impacts, the overall sentiment is positive due to robust financial performance and strategic scaling efforts.
Evolv Technologies Holdings, Inc. (EVLV) Q1 2026 Earnings Call Transcript
Positive5-13
The earnings call summary indicates strong financial performance with a 35% revenue increase and improved gross margins, despite a net loss. The strategic partnership with Plexus is a positive development, and the company's focus on growth and market opportunities is promising. However, the lack of specific guidance and mention of risks in forward-looking statements tempers the sentiment slightly. Overall, the positive financial metrics and strategic initiatives suggest a positive outlook for stock price movement.
Evolv Technologies Holdings, Inc. (EVLV) Q4 2025 Earnings Call Transcript
Positive3-10
The earnings call summary indicates strong financial performance with a 40% increase in full-year revenue and a significant improvement in adjusted EBITDA. The Q&A section revealed positive sentiment towards future revenue growth, driven by strategic changes and anticipated ARR acceleration. Despite some execution risks, the company's strategic initiatives, including the Plexus partnership and AHA certification, are expected to enhance growth. The raised revenue guidance and positive cash flow expectations for 2026 further support a positive outlook, suggesting a likely stock price increase of 2% to 8%.
EVLV Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
